Use of biomarkers in the management of children with lupus (Q38077151)

28 August 2017

1 reference

title

Use of biomarkers in the management of children with lupus (English)

1 reference

28 August 2017

0 references

Elisabeth Binder

1

1 reference

PubMed ID

23355230

28 August 2017

Monika Edelbauer

series ordinal

2

1 reference

28 August 2017

1 March 2013

1 reference

Current Rheumatology Reports

28 August 2017

1 reference

28 August 2017

15

1 reference

28 August 2017

3

1 reference

28 August 2017

312

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-012-0312-0

28 August 2017

0 references

cites work

Epigenetic regulation and the pathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Biomarkers for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Urine biomarkers in juvenile-onset SLE nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

The search for lupus biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Two major autoantibody clusters in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Usefulness of antinuclear antibody testing to screen for rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Clinical utility of antinuclear antibody tests in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Biomarkers for lupus nephritis: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Predictors of survival in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Renal disease associated with inherited disorders of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Genetics of human systemic lupus erythematosus: the emerging picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Current status of lupus genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

The intricate role of complement component C4 in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Impact of C1q deficiency on the severity and outcome of childhood systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

The genetics and biology of Irf5-mediated signaling in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

The classification of glomerulonephritis in systemic lupus erythematosus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Identification of a urinary proteomic signature for lupus nephritis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Pediatric SLE--towards a comprehensive management plan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0312-0

Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus

21 January 2018

1 reference

12 December 2020

Platelet C4d is highly specific for systemic lupus erythematosus

1 reference

12 December 2020

Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus

1 reference

12 December 2020

Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus.

1 reference

12 December 2020

Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure

1 reference

12 December 2020

Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis

1 reference

12 December 2020

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95

1 reference

12 December 2020

Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus

1 reference

12 December 2020

Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients

1 reference

12 December 2020

Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker

1 reference

12 December 2020

Renal tubular dysfunction in children with systemic lupus erythematosus

1 reference

12 December 2020

The value of complement activation products in the assessment of systemic lupus erythematosus flares

1 reference

12 December 2020

Biomarker discovery in human SLE nephritis.

1 reference

12 December 2020

Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus

1 reference

12 December 2020

Further description of early clinically silent lupus nephritis

1 reference

12 December 2020

Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus

1 reference

12 December 2020

Cellular localization of nuclear antigen during neutrophil apoptosis: mechanism for autoantigen exposure?

1 reference

12 December 2020

HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S11926-012-0312-0

Identifiers

DOI

1 reference

PubMed ID

23355230

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23355230